Clinical trial
Development of a Health-Related Symptom Index for Spanish-Speaking Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)
NCT04276935 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Health-Related Symptom Index for Spanish-Speaking Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)
- Lead sponsor
- AIDS Malignancy Consortium
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 6, 2018
- Completion date
- March 1, 2020
- Enrollment
- 20 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
high grade anal canal squamous intraepithelial neoplasia, human immunodeficiency virus